diaminotriazines (Collaborations Pharmaceuticals)

N/A

Report date: 2025/03/19 08:57:50
NME

Base Information

Drug Namediaminotriazines (Collaborations Pharmaceuticals)
Drug Alias NameJSF-2032 analogs (Collaborations Pharmaceuticals)
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsTuberculosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsTuberculosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A